RT @drdavidliew: It's always amazed me adalimumab & abatacept, have very different MOA but similar efficacy in RA -

David Liew @drdavidliew Nov 12, 2022

It's always amazed me adalimumab & abatacept, have very different MOA but similar efficacy in RA - on a population level.

Not for individuals, though. Surely we can pick the winners better?
Lovely biomarker work from a H2H RCT
ABST0244 #ACR22 @RheumNow